Last updated 7 months ago

A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer

300 patients around the world
Available in Argentina
GlaxoSmithKline
8Research sites
300Patients around the world
This study is for people with
Lung cancer
Non-small cell lung carcinoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Centro Polivalente de Asistencia e Investigación Clínica - CER San Juan
Centro Polivalente de Asistencia e Investigación Clínica - CER San Juan
Recruiting
Laprida 532 Este, San Juan
CEMIC - Hospital Universitario Sede Saavedra - CABA, Buenos Aires
CEMIC - Hospital Universitario Sede Saavedra - CABA, Buenos Aires
Recruiting
Av. Galvan 4102, CABA, Buenos Aires
Clínica Adventista Belgrano - CABA - Buenos Aires
Clínica Adventista Belgrano - CABA - Buenos Aires
Recruiting
Estomba 1710, CABA, Buenos Aires
Centro Médico Fleischer
Recruiting
CABA, C1414
Dra. Susana Vighi - Centro de Anatomía Patológica
Recruiting
Cdad. de la Paz 353, C1426 Cdad. Autónoma de Buenos Aires, Argentina
Fundación Médica de Río Negro y Neuquén - Cipolletti
Recruiting
Av. Mengelle 273, Cipolletti, Río Negro
Fundación Respirar
Recruiting
Av. Cabildo 1548, CABA, Buenos Aires
Laboratorio Haleon Argentina
Recruiting
Carlos Casares 3690, B1644BCD San Fernando, Provincia de Buenos Aires, Argentina
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy